Category icon
Redefining the Standard for Atrial Fibrillation: A Patient-centric Report

Carina Blomström-Lundqvist, Helmut Pürerfellner, Alex White, et al

Category icon
First-in-Human Use of the Next-generation ProtEmbo Cerebral Embolic…

Dariusz Jagielak, Radoslaw Targonski, Dariusz Ciecwierz,

Category icon
Removal of the ProtEmbo from the Aortic Arch

Dariusz Jagielak, Radoslaw Targonski, Dariusz Ciecwierz

Category icon
Patent Foramen Ovale Closure: State of the Art

Joel P Giblett, Lynne K Williams, Stephen Kyranis, et al

Category icon
HDL Cholesterol and Adverse Outcomes

Marc P Allard-Ratick, Pratik Sandesara, Arshed A Quyyumi, et al

Category icon
Patent Foramen Ovale Closure in 2019

Joel P Giblett, Omar Abdul-Samad, Leonard M Shapiro, et al

Category icon
Cerebral Embolic Protection in TAVI: Friend or Foe

Michael Teitelbaum, Rafail Kotronias, Luciano A Sposato, et al

Category icon
Gender and Atrial Fibrillation: Differences and Disparities

Naga Venkata Pothineni, Srikanth Vallurupalli,

About

Several clinical and non-clinical risk factors for stroke in patients with atrial fibrillation have been identified, and clinically useful classification schemes have been developed to facilitate risk stratification in these patients.

Both a history of hypertension and systolic blood pressure >160 mmHg have been shown to be consistent independent risk factors for stroke, resulting in a twofold increase in stroke risk.

Related Articles

Articles

Article icon
Redefining the Standard for Atrial Fibrillation: A Patient-centric Report

Carina Blomström-Lundqvist, Helmut Pürerfellner, Alex White,

Published:

Citation: European Cardiovascular Review 2021;16(Suppl 1):1–6.

First-in-Human Use of the Next-generation ProtEmbo Cerebral Embolic…

Dariusz Jagielak, Radoslaw Targonski, Dariusz Ciecwierz,

Published:

Citation: Interventional Cardiology Review 2021;16(Suppl 1):1–4.

Patent Foramen Ovale Closure: State of the Art

Joel P Giblett, Lynne K Williams, Stephen Kyranis,

Published:

Citation: Interventional Cardiology Review 2020;15:e15.

HDL Cholesterol and Adverse Outcomes

Marc P Allard-Ratick, Pratik Sandesara, Arshed A Quyyumi,

Published:

Citation: US Cardiology Review 2019;13(1):49–53